Table 4.

First-time prescriber rates for SGLT2 inhibitors or GLP1 receptor agonists by clinical specialty in integrated health system clinics

Variable	2013	2014	2015	2016	2017	2018	2019	Absolute difference 2013–2019	95% confidence interval
Total Prescriptions (n)	524	388	535	465	549	952	2031	–	–
Clinician Specialty (%)
Endocrinology	80%	75%	78%	67%	60%	49%	29%	51%	46%–56%
Primary Care	8%	6%	2%	3%	4%	24%	57%	49%	44%–54%
Cardiology	9%	13%	14%	13%	14%	12%	14%	5%	3%–7%
Nephrology	0%	1%	0%	1%	0%	0%	0%	0%	0%

Prescriptions were defined as first-time if it was the initial prescription for an SGLT2 inhibitor or GLP1 receptor agonist identified in the Northwestern Medicine Electronic Data Warehouse.